These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 18986787

  • 1. [Are there differences in immunogenicity and safety of vaccines according to the injection method?].
    Ajana F, Sana C, Caulin E.
    Med Mal Infect; 2008 Dec; 38(12):648-57. PubMed ID: 18986787
    [Abstract] [Full Text] [Related]

  • 2. Vaccine injection technique and reactogenicity--evidence for practice.
    Petousis-Harris H.
    Vaccine; 2008 Nov 25; 26(50):6299-304. PubMed ID: 18804137
    [Abstract] [Full Text] [Related]

  • 3. Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature.
    Herzog C.
    Expert Rev Vaccines; 2014 Mar 25; 13(3):399-415. PubMed ID: 24512188
    [Abstract] [Full Text] [Related]

  • 4. Optimal intramuscular needle-penetration depth.
    Lippert WC, Wall EJ.
    Pediatrics; 2008 Sep 25; 122(3):e556-63. PubMed ID: 18694903
    [Abstract] [Full Text] [Related]

  • 5. Prospective assessment of the effect of needle length and injection site on the risk of local reactions to the fifth diphtheria-tetanus-acellular pertussis vaccination.
    Jackson LA, Starkovich P, Dunstan M, Yu O, Nelson J, Dunn J, Rees T, Zavitkovsky A, Maus D, Froeschle JE, Decker M.
    Pediatrics; 2008 Mar 25; 121(3):e646-52. PubMed ID: 18310184
    [Abstract] [Full Text] [Related]

  • 6. Ventrogluteal area--a suitable site for intramuscular vaccination of infants and toddlers.
    Cook IF, Murtagh J.
    Vaccine; 2006 Mar 20; 24(13):2403-8. PubMed ID: 16406175
    [Abstract] [Full Text] [Related]

  • 7. Safety and immunogenicity of subcutaneous or intramuscular administration of a monovalent inactivated vaccine against Leptospira interrogans serogroup Icterohaemorrhagiae in healthy volunteers.
    Laurichesse H, Gourdon F, Smits HL, Abdoe TH, Estavoyer JM, Rebika H, Pouliquen P, Catalina P, Dubray C, Beytout J.
    Clin Microbiol Infect; 2007 Apr 20; 13(4):395-403. PubMed ID: 17359323
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
    Künzi V, Klap JM, Seiberling MK, Herzog C, Hartmann K, Kürsteiner O, Kompier R, Grimaldi R, Goudsmit J.
    Vaccine; 2009 Jun 02; 27(27):3561-7. PubMed ID: 19464535
    [Abstract] [Full Text] [Related]

  • 9. Vaccination site and risk of local reactions in children 1 through 6 years of age.
    Jackson LA, Peterson D, Nelson JC, Marcy SM, Naleway AL, Nordin JD, Donahue JG, Hambidge SJ, Balsbaugh C, Baxter R, Marsh T, Madziwa L, Weintraub E.
    Pediatrics; 2013 Feb 02; 131(2):283-9. PubMed ID: 23319538
    [Abstract] [Full Text] [Related]

  • 10. Comparative reactogenicity and immunogenicity of 23 valent pneumococcal vaccine administered by intramuscular or subcutaneous injection in elderly adults.
    Cook IF, Pond D, Hartel G.
    Vaccine; 2007 Jun 15; 25(25):4767-74. PubMed ID: 17512098
    [Abstract] [Full Text] [Related]

  • 11. Needle length and injection technique for efficient intramuscular vaccine delivery.
    Aggarwal A.
    Indian Pediatr; 1998 Apr 15; 35(4):389-91. PubMed ID: 9770904
    [No Abstract] [Full Text] [Related]

  • 12. Definition of needle length required for intramuscular deltoid injection in elderly adults: an ultrasonographic study.
    Cook IF, Williamson M, Pond D.
    Vaccine; 2006 Feb 13; 24(7):937-40. PubMed ID: 16191454
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunization injections.
    Hammer SJ, Backer H, Schechter R.
    Arch Pediatr Adolesc Med; 2004 Jul 13; 158(7):708; author reply 709. PubMed ID: 15237075
    [No Abstract] [Full Text] [Related]

  • 16. Anterolateral thigh measurements by ultrasound in neonates and young infants to ensure safe intramuscular injections during vaccination in low- and middle-income countries.
    Bhowmick R, Bharti B, Kumar P, Saxena AK, Bharti S.
    J Trop Pediatr; 2020 Apr 01; 66(2):114-120. PubMed ID: 31237946
    [Abstract] [Full Text] [Related]

  • 17. Choosing a route of administration for quadrivalent meningococcal polysaccharide vaccine: intramuscular versus subcutaneous.
    Ruben FL, Froeschle JE, Meschievitz C, Chen K, George J, Reeves-Hoché MK, Pietrobon P, Bybel M, Livingood WC, Woodhouse L.
    Clin Infect Dis; 2001 Jan 01; 32(1):170-2. PubMed ID: 11118395
    [Abstract] [Full Text] [Related]

  • 18. Technologies that make administration of vaccines safer.
    Clements CJ, Larsen G, Jodar L.
    Vaccine; 2004 May 07; 22(15-16):2054-8. PubMed ID: 15121322
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
    Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y.
    Vaccine; 2009 Jan 14; 27(3):454-9. PubMed ID: 19022318
    [Abstract] [Full Text] [Related]

  • 20. Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes.
    Tubiana-Rufi N, Belarbi N, Du Pasquier-Fediaevsky L, Polak M, Kakou B, Leridon L, Hassan M, Czernichow P.
    Diabetes Care; 1999 Oct 14; 22(10):1621-5. PubMed ID: 10526725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.